Here at Omnicell, we are entering 2025 with a renewed ... with the addition of XT Cabinet automation and the expansion of anesthesia dispensing automation and software in order to support care ...

It's been a mediocre week for Omnicell, Inc. (NASDAQ:OMCL) shareholders, with the stock dropping 11% to US$40.16 in the week since its latest annual results. Revenues were US$1.1b, approximately ...

FORT WORTH, Texas, February 06, 2025--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in ...

CEO Randall Lipps highlighted that Omnicell exceeded bookings guidance for 2024, driven by strong connected devices demand. He emphasized the traction of the XT Amplify program and new customer ...

For the current quarter ending in March, Omnicell expects its per-share earnings to range from 15 cents to 25 cents. The company said it expects revenue in the range of $255 million to $265 ...

In light of that, when we looked at Omnicell (NASDAQ:OMCL) and its ROCE trend, we weren't exactly thrilled. For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return ...

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more. We sell different types of products and services to both investment ...